TSXV:CLAS.H - Post by User
Post by
edroseon Apr 24, 2020 9:50am
130 Views
Post# 30948797
How can a biotech with extremely good phase 2 results to
How can a biotech with extremely good phase 2 results toTreat a condition where there’s no CURRENT TREATMENT and these patients often die without treatment fda granted orphan drug designation,fast tract Be only .02 and ceo/management/board of directors state NOT ONE COMPANY IS INTETESTED IN KLY AND IMPOSSIBLE TO RAISE MONEY
ALSO WHAT HAPPENED TO THE 10 MILLION PRIVATE PLACEMENT
THIS DOESNT ADD UP